Dr. Greiner is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
500 University, MC H085
Penn State Hershey Children's Hospital
Hershey, PA 17033Phone+1 717-531-6012Fax+1 717-531-4789
Summary
- Robert Greiner, MD, is a pediatric hematologist and oncologist based in Hershey, PA, with subspecialties in hematologic, neuro, sarcoma and solid tumor oncology. His education includes a fellowship in pediatric hematology/oncology from Duke University Hospital and an undergraduate degree where he graduated cum laude from the University of Delaware. Notably, he's currently serving as the Director of the Pediatric Stem Cell Transplant Program at Penn State Hershey Childrens Hospital and as an Associate Professor at Penn State Health and Penn State Milton S. Hershey Medical Center. His professional experience covers pediatric bone marrow transplantation. His published work spans a variety of topics related to his field and he has participated in clinical trials such as MRD Testing Before and After Hematopoietic Cell Transplantation for Pediatric Acute Myeloid Leukemia.
Education & Training
- Duke University HospitalFellowship, Pediatric Hematology/Oncology, 2006 - 2009
- Inova Fairfax Medical Campus/Inova Children's HospitalResidency, Pediatrics, 2003 - 2006
- Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 2003
- University of DelawareBachelor of Arts, Double Major in Biology and Liberal Studies, Graduated Cum Laude, 1993 - 1999
Certifications & Licensure
- PA State Medical License 2009 - 2024
- NC State Medical License 2006 - 2009
- VA State Medical License 2003 - 2006
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- MRD Testing Before and After Hematopoietic Cell Transplantation for Pediatric Acute Myeloid Leukemia Start of enrollment: 2011 Oct 01
Publications & Presentations
PubMed
- 25 citationsOutcomes of Measurable Residual Disease in Pediatric Acute Myeloid Leukemia before and after Hematopoietic Stem Cell Transplant: Validation of Difference from Normal F...David A. Jacobsohn, Michael R. Loken, Mingwei Fei, Alexia Adams, Lisa Eidenschink Brodersen
Biology of Blood and Marrow Transplantation. 2018-10-01 - 124 citationsTreatment with sirolimus results in complete responses in patients with autoimmune lymphoproliferative syndromeDavid T. Teachey, Robert J. Greiner, Alix E. Seif, Edward F. Attiyeh, Jack J. Bleesing
British Journal of Haematology. 2009-04-01 - 3 citationsHematopoietic Cell Transplantation for Congenital Dyserythropoietic Anemia: A Report from the Pediatric Transplant and Cellular Therapy Consortium.Hemalatha G Rangarajan, Joseph R Stanek, Hisham Abdel-Azim, Arunkumar Modi, Ann Haight
Transplantation and Cellular Therapy. 2022-06-01
Professional Memberships
- American Society for Blood and Marrow TransplantationMember
- Children's Oncology GroupMember
- American Society of Pediatric Hematology OncologyMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: